MedPath

ong-term efficacy and safety of the SGLT2 inhibitors in Japanese patients with type 2 diabetes mellitus.

Not Applicable
Conditions
Type 2 Diabetes mellitus
Registration Number
JPRN-UMIN000037872
Lead Sponsor
akakinen Clinic
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
630
Inclusion Criteria

Not provided

Exclusion Criteria

Participation in the study is judged by the investigator or sub-investigator as inappropriate for any other reason

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath